Mitsuyoshi Namba

5.1k total citations
118 papers, 3.0k citations indexed

About

Mitsuyoshi Namba is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Molecular Biology. According to data from OpenAlex, Mitsuyoshi Namba has authored 118 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 73 papers in Endocrinology, Diabetes and Metabolism, 50 papers in Surgery and 29 papers in Molecular Biology. Recurrent topics in Mitsuyoshi Namba's work include Diabetes Management and Research (46 papers), Pancreatic function and diabetes (45 papers) and Diabetes Treatment and Management (41 papers). Mitsuyoshi Namba is often cited by papers focused on Diabetes Management and Research (46 papers), Pancreatic function and diabetes (45 papers) and Diabetes Treatment and Management (41 papers). Mitsuyoshi Namba collaborates with scholars based in Japan, United Kingdom and Australia. Mitsuyoshi Namba's co-authors include Toshiaki Hanafusa, Yūji Matsuzawa, Jun‐ichiro Miyagawa, Jun-ichiro Miyagawa, Hiromi Iwahashi, Hiromu Nakajima, Tatsuo Matsuyama, Norio Kôno, Kazuya Yamagata and Tomoyuki Katsuno and has published in prestigious journals such as The Journal of Experimental Medicine, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Mitsuyoshi Namba

116 papers receiving 2.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mitsuyoshi Namba Japan 32 1.4k 1.4k 905 878 302 118 3.0k
Lisa Juntti‐Berggren Sweden 27 740 0.5× 1.3k 1.0× 509 0.6× 1.1k 1.3× 387 1.3× 72 2.6k
Per‐Ola Carlsson Sweden 28 1.3k 0.9× 1.5k 1.1× 897 1.0× 657 0.7× 548 1.8× 91 3.2k
Alberto M. Davalli Italy 28 1.1k 0.8× 1.9k 1.3× 1.1k 1.2× 840 1.0× 374 1.2× 65 3.3k
S. Sandler Sweden 31 1.1k 0.8× 1.8k 1.3× 1.3k 1.4× 669 0.8× 449 1.5× 94 2.9k
Leen M. ‘t Hart Netherlands 30 775 0.5× 818 0.6× 663 0.7× 1.5k 1.7× 424 1.4× 98 3.0k
Hans Kofod Denmark 22 1.5k 1.1× 1.4k 1.0× 508 0.6× 853 1.0× 378 1.3× 47 2.7k
Susanne M. Clee Canada 32 1.0k 0.7× 2.2k 1.6× 509 0.6× 1.6k 1.9× 756 2.5× 54 4.1k
Hideichi Makino Japan 38 1.5k 1.1× 1.5k 1.1× 1.3k 1.5× 1.2k 1.4× 887 2.9× 156 4.2k
Delbert G. Gillespie United States 37 695 0.5× 293 0.2× 716 0.8× 1.3k 1.4× 377 1.2× 102 3.7k
John A Galloway United States 27 1.7k 1.2× 1.2k 0.8× 711 0.8× 763 0.9× 390 1.3× 57 2.8k

Countries citing papers authored by Mitsuyoshi Namba

Since Specialization
Citations

This map shows the geographic impact of Mitsuyoshi Namba's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mitsuyoshi Namba with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mitsuyoshi Namba more than expected).

Fields of papers citing papers by Mitsuyoshi Namba

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mitsuyoshi Namba. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mitsuyoshi Namba. The network helps show where Mitsuyoshi Namba may publish in the future.

Co-authorship network of co-authors of Mitsuyoshi Namba

This figure shows the co-authorship network connecting the top 25 collaborators of Mitsuyoshi Namba. A scholar is included among the top collaborators of Mitsuyoshi Namba based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mitsuyoshi Namba. Mitsuyoshi Namba is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Katsuno, Tomoyuki, Toshihiko Shiraiwa, Hyohun Park, et al.. (2021). Benefit of Early Add-on of Linagliptin to Insulin in Japanese Patients With Type 2 Diabetes Mellitus: Randomized-Controlled Open-Label Trial (TRUST2). Advances in Therapy. 38(3). 1514–1535. 3 indexed citations
2.
Namba, Mitsuyoshi, Toshio Iwakura, Rimei Nishimura, et al.. (2018). The current status of treatment‐related severe hypoglycemia in Japanese patients with diabetes mellitus: A report from the committee on a survey of severe hypoglycemia in the Japan Diabetes Society. Journal of Diabetes Investigation. 9(3). 642–656. 39 indexed citations
3.
Kadoya, M, Akiko Morimoto, Akio Miyoshi, et al.. (2017). Serum Macro TSH Level is Associated with Sleep Quality in Patients with Cardiovascular Risks – HSCAA Study. Scientific Reports. 7(1). 44387–44387. 19 indexed citations
4.
Kusunoki, Yoshiki, Takayo Murase, Takashi Nakamura, et al.. (2017). Xanthine oxidoreductase activity is correlated with insulin resistance and subclinical inflammation in young humans. Metabolism. 70. 51–56. 53 indexed citations
5.
Kadoya, M, Hidenori Koyama, Masafumi Kurajoh, et al.. (2016). Associations of Sleep Quality and Awake Physical Activity with Fluctuations in Nocturnal Blood Pressure in Patients with Cardiovascular Risk Factors. PLoS ONE. 11(5). e0155116–e0155116. 17 indexed citations
6.
7.
Konya, Hiroyuki, et al.. (2013). Effects of combination therapy with mitiglinide and voglibose on postprandial plasma glucose in patients with type 2 diabetes mellitus. SHILAP Revista de lepidopterología. 2 indexed citations
8.
Konya, Hiroyuki, Tomoyuki Katsuno, Masayuki Miuchi, et al.. (2013). Effects of combination therapy with mitiglinide and voglibose on postprandial plasma glucose in patients with type 2 diabetes mellitus. Diabetes Metabolic Syndrome and Obesity. 6. 317–317. 13 indexed citations
9.
Namba, Mitsuyoshi, Tomoyuki Katsuno, Yoshiki Kusunoki, et al.. (2012). New strategy for the treatment of type 2 diabetes mellitus with incretin-based therapy. Clinical and Experimental Nephrology. 17(1). 10–15. 18 indexed citations
10.
Hamaguchi, Tomoya, Masafumi Koga, Jun Murai, et al.. (2011). Estimation of HbA1c response to sitagliptin by change in glycated albumin level for 2 weeks. Journal of Diabetes Investigation. 3(2). 175–178. 10 indexed citations
11.
Katsuno, Tomoyuki, Tomoya Hamaguchi, J Miyagawa, et al.. (2010). Asymmetric dimetylarginine (ADMA) could affect on cardiovascular complications in type 2 diabetes, particularly complicated with nephropathy. Endocrine Journal. 57. 378. 1 indexed citations
12.
Namba, Mitsuyoshi. (2006). The socio-medical issues of elderly diabetic patients. Nippon Ronen Igakkai Zasshi Japanese Journal of Geriatrics. 43(6). 700–701. 1 indexed citations
13.
Konya, Hiroyuki, Tomoya Hamaguchi, Tomoyuki Katsuno, et al.. (2006). Clinical significance of circulating hepatocyte growth factor, a new risk marker of carotid atherosclerosis in patients with Type 2 diabetes. Diabetic Medicine. 23(6). 617–622. 27 indexed citations
14.
Hasegawa, Yoshikazu, Akira Suehiro, Satoshi Higasa, Mitsuyoshi Namba, & Eizo Kakishita. (2002). Enhancing effect of advanced glycation end products on serotonin-induced platelet aggregation in patients with diabetes mellitus. Thrombosis Research. 107(6). 319–323. 56 indexed citations
15.
Yang, Qin, Kazuya Yamagata, Koji Yamamoto, et al.. (1999). Structure/Function Studies of Hepatocyte Nuclear Factor-1α, a Diabetes-Associated Transcription Factor. Biochemical and Biophysical Research Communications. 266(1). 196–202. 34 indexed citations
16.
Moriwaki, Masamitsu, Naoto Itoh, Jun-ichiro Miyagawa, et al.. (1999). Fas and Fas ligand expression in inflamed islets in pancreas sections of patients with recent-onset Type I diabetes mellitus. Diabetologia. 42(11). 1332–1340. 122 indexed citations
17.
Iwahashi, Hiromi, Toshiaki Hanafusa, Yawara Eguchi, et al.. (1996). Cytokine-induced apoptotic cell death in a mouse pancreatic beta-cell line: inhibition by Bcl-2. Diabetologia. 39(5). 530–536. 108 indexed citations
18.
Miki, Hiroyuki, Mitsuyoshi Namba, Ikuo Mineo, et al.. (1996). Glucagon-like peptide-1(7-36) amide enhances insulin-stimulated glucose uptake and decreases intracellular cAMP content in isolated rat adipocytes. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1312(2). 132–136. 30 indexed citations
19.
Itoh, H., Tatsuo Matsuyama, Mitsuyoshi Namba, et al.. (1989). Effect of glucagon-(1–21)-peptide on secretin-stimulated pancreatic exocrine secretion in anesthetized dogs. Life Sciences. 44(12). 819–825. 5 indexed citations
20.
Matsuyama, Tatsuo, et al.. (1988). Glucagon-like peptide-1 (7–36 amide): a potent glucagonostatic and insulinotropic hormone. Diabetes Research and Clinical Practice. 5(4). 281–284. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lisa Juntti‐Berggren Breakdown of academic impact, for papers by Per‐Ola Carlsson Breakdown of academic impact, for papers by Alberto M. Davalli Breakdown of academic impact, for papers by S. Sandler Breakdown of academic impact, for papers by Leen M. ‘t Hart Breakdown of academic impact, for papers by Hans Kofod Breakdown of academic impact, for papers by Susanne M. Clee Breakdown of academic impact, for papers by Hideichi Makino Breakdown of academic impact, for papers by Delbert G. Gillespie Breakdown of academic impact, for papers by John A Galloway
Rankless by CCL
2026